Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Investigate the Function, Safety and Tolerability of a Transdermal Continuous Glucose Monitoring System in Diabetic Patients (Type 1 and 2) for a Period of 28 Days

NCT06868043 is registered in ClinicalTrials.gov with EyeSense GmbH as lead sponsor.

NCT NCT06868043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06868043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Investigate the Function, Safety and Tolerability of a Transdermal Continuous Glucose Monitoring System in Diabetic Patients (Type 1 and 2) for a Period of 28 Days
Lead sponsor
EyeSense GmbH
Phase
Not applicable
Overall status
Terminated
Start date
July 31, 2012
Completion date
June 30, 2014
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes (dm)